Lafayette Investments’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-2,642
Closed -$432K 78
2017
Q4
$432K Hold
2,642
0.15% 51
2017
Q3
$541K Hold
2,642
0.2% 48
2017
Q2
$642K Hold
2,642
0.24% 45
2017
Q1
$631K Hold
2,642
0.23% 45
2016
Q4
$555K Hold
2,642
0.21% 46
2016
Q3
$608K Hold
2,642
0.25% 43
2016
Q2
$611K Hold
2,642
0.25% 42
2016
Q1
$708K Hold
2,642
0.29% 40
2015
Q4
$826K Hold
2,642
0.34% 42
2015
Q3
$718K Hold
2,642
0.31% 41
2015
Q2
$802K Hold
2,642
0.34% 39
2015
Q1
$786K Buy
+2,642
New +$753K 0.33% 39

Other funds holding AGN

Lafayette Investments's AGN Position: Q1 2018 in Review

Lafayette Investments sold out of Allergan plc (AGN) in Q1 2018, closing a stake of 2,642 shares — an estimated $432K sold.

Lafayette Investments first reported a position in AGN in Q1 2015 and held it in 12 quarters. The position peaked at $826K in Q4 2015. 1,022 funds tracked by Wall St. Rank hold AGN as of Q1 2018.

  • Lafayette Investments reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • Lafayette Investments sold 2,642 Allergan plc shares in Q1 2018, an estimated $432K.
  • Lafayette Investments first reported a position in Allergan plc in Q1 2015 and held it in 12 quarters.
  • Lafayette Investments's Allergan plc position peaked at $826K in Q4 2015.
  • 1,022 funds tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Lafayette Investments's 13F filing for Q1 2018, filed 15 May 2018.